Agarose for a bioartificial pancreas. 1992

H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
National Cardiovascular Center Research Institute, Osaka, Japan.

Islets were encapsulated into 5% concentration agarose microbeads. The effect of microencapsulation on islet allograft survivals was determined using a streptozotocin-induced diabetic (STZ) mouse and a nonobese diabetic (NOD) mouse as recipients. All five STZ BALB/c mice receiving microencapsulated islets (C57BL/6) maintained normoglycemia indefinitely. When NOD mice were used as recipients of the bioartificial pancreas, four of five grafts (islets from C3H/He) functioned for more than 80 d. Two of five NOD mice maintained normoglycemia until animals were sacrificed at 102 and 192 postoperative d. Microbeads made of commercially available agarose can effectively prolong alloislets functioning in the STZ-diabetic mouse and even in the NOD mouse (animal model of human type I diabetes) without the use of any immunosuppressive drug.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D005260 Female Females
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012685 Sepharose Agarose,Sepharose 4B,Sepharose C1 4B,4B, Sepharose C1,C1 4B, Sepharose

Related Publications

H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
January 2009, Transplantation,
H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
April 1990, Transplantation proceedings,
H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
April 1994, Transplantation proceedings,
H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
March 1993, Diabetic medicine : a journal of the British Diabetic Association,
H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
September 2002, Nihon rinsho. Japanese journal of clinical medicine,
H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
October 2010, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
January 2013, Pathobiology : journal of immunopathology, molecular and cellular biology,
H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
February 2006, Tissue engineering,
H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
December 2013, Artificial organs,
H Iwata, and T Takagi, and H Amemiya, and H Shimizu, and K Yamashita, and K Kobayashi, and T Akutsu
January 1990, Hormone and metabolic research. Supplement series,
Copied contents to your clipboard!